ArticleMedicine2025
Causal analysis of the National Chronic Disease Management Program on intracerebral hemorrhage mortality.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intracerebral hemorrhage (ICH) significantly contributes to mortality and long-term disability, particularly in low- and middle-income countries (LMICs) like Vietnam. ICH prevalence is higher in individuals with chronic diseases, particularly with poor treatment adherence. This study aims to evaluate the impact of the outpatient treatment strategy with the National Chronic Disease Management Program (NCDMP), implemented in Vietnam, on the intracerebral hemorrhage mortality rate per 100,000 individuals (IHMR100k) from 2010 to 2019. National IHMR100k data were analyzed over the period, employing the 'CausalImpact' method to assess the causal effect of the NCDMP intervention, with data from the end of 2016 serving as the baseline for comparison. Analysis of the national mortality data over the period (2010-2019) revealed significant changes in mortality rates due to ICH, with the IHMR100k showing a gradual decline over time, reaching a low of 0.44 in 2019, although it remained among the top 10 causes of death. The implementation of the NCDMP strategy contributed to a decline in IHMR100k from 0.88 in 2010 to 0.44 in 2019. The Causal Impact analysis indicated that the actual average mortality rate was 0.54, lower than the predicted mean of 0.75. The absolute effect of the intervention was -0.21 (95% CI: -0.34 to -0.08), signifying a substantial reduction in mortality rates associated with ICH. The findings indicate that the NCDMP effectively reduced ICH mortality rates in Vietnam. This underscores the importance of sustainable outpatient care strategies for managing chronic diseases, enhancing medication access, and improving health outcomes in LMICs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.